Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesExchange Rate EffectFree Cash FlowNet Cash FlowNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Cash from Financing Activities: 2019-2025

Historic Cash from Financing Activities for Burning Rock Biotech (BNR) over the last 5 years, with Jun 2025 value amounting to $2.0 million.

  • Burning Rock Biotech's Cash from Financing Activities was N/A to $2.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of -$10,000 for FY2024, which is 99.85% up from last year.
  • According to the latest figures from Q2 2025, Burning Rock Biotech's Cash from Financing Activities is $2.0 million, which was up 20,100.00% from -$10,000 recorded in Q4 2024.
  • Burning Rock Biotech's Cash from Financing Activities' 5-year high stood at $2.0 million during Q2 2025, with a 5-year trough of -$46.9 million in Q3 2023.
  • Over the past 3 years, Burning Rock Biotech's median Cash from Financing Activities value was -$42,000 (recorded in 2024), while the average stood at -$5.8 million.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first crashed by 1,656.76% in 2023, then surged by 100.00% in 2024.
  • Over the past 5 years, Burning Rock Biotech's Cash from Financing Activities (Quarterly) stood at -$1.1 million in 2021, then crashed by 1,073.99% to -$12.5 million in 2022, then surged by 97.85% to -$269,000 in 2023, then skyrocketed by 96.28% to -$10,000 in 2024, then reached $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q2 2025, -$10,000 for Q4 2024, and $279.06 during Q3 2024.